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Adenosine-to-inosine RNA editing, catalyzed by adenosine deaminase acting on RNA (ADAR) enzymes, alters
RNAsequences from thoseencodedbyDNA. Theseeditingevents aredynamically regulated, but few trans reg-
ulators of ADARs are known in vivo. Here, we screen RNA-binding proteins for roles in editing regulation with
knockdown experiments in the Drosophila brain. We identify zinc-finger protein at 72D (Zn72D) as a regulator
of editing levels at amajority of editing sites in thebrain. Zn72Dboth regulates ADARprotein levels and interacts
with ADAR in an RNA-dependent fashion, and similar to ADAR, Zn72D is necessary to maintain proper neuro-
muscular junctionarchitectureandflymobility. Furthermore,Zn72D’s regulatory role inRNAediting isconserved
because the mammalian homolog of Zn72D, Zfr, regulates editing in mouse primary neurons. The broad and
conserved regulation of ADAR editing by Zn72D in neurons sustains critically important editing events.
INTRODUCTION
RNA editing expands genetic diversity by altering bases en-
coded by the genome at the RNA level (Eisenberg and Levanon,
2018; Nishikura, 2016). The deamination of adenosine (A) into
inosine (I), a highly prevalent form of mRNA editing, is catalyzed
by adenosine deaminase acting on RNA (ADAR) proteins, which
are double-stranded RNA-binding proteins that are conserved in
metazoans (Bass, 2002). Inosine is recognized by the cellular
machinery as guanosine (G); therefore, a single editing event in
RNA has the ability to disrupt regulatory mechanisms or to
change the protein encoded by the transcript by altering a codon
or splice site (Nishikura, 2010). Millions of these RNA editing sites
have been identified, necessitating a better understanding of
how this process is regulated (Walkley and Li, 2017).
Proper regulation of ADAR proteins and A-to-I RNA editing is
essential to organismal health. Humans have two catalytically
active ADAR proteins, and functional changes in both proteins
are associated with disease. ADAR1 edits endogenous double-
stranded RNA, which is critical for proper innate immune func-
tion (Liddicoat et al., 2015; Mannion et al., 2014; Pestal et al.,
2015), and loss of ADAR1 sensitizes tumors to regression (Gan-
non et al., 2018; Ishizuka et al., 2019; Liu et al., 2019). ADAR2
edits of a number of ion channels important for regulating
neuronal excitability (Rosenthal and Seeburg, 2012), and its dys-
regulation is associated with a host of neurological diseases
including amyotrophic lateral sclerosis, astrocytoma, and tran-
sient forebrain ischemia (Slotkin and Nishikura, 2013). In
Drosophila, loss of the single Adar homolog, most akin to
mammalian Adar2, alters fly locomotion, courtship behaviors,
and sleep (Jepson et al., 2011; Robinson et al., 2016); changes
synaptic architecture (Bhogal et al., 2011; Maldonado et al.,
2013); and leads to neurodegeneration (Palladino et al., 2000).
Although maintaining RNA editing levels is critical for proper im-
mune and neuronal function, the regulation of ADAR proteins
and editing levels is poorly understood.
Recent studies suggest that regulation of RNA editing levels is
highly complex and that critical RNA editing regulators have yet
to be identified. RNA editing levels differ across tissues and
developmental stages, and these changes do not always corre-
late with Adar mRNA or protein expression (Sapiro et al., 2019;
Tan et al., 2017; Wahlstedt et al., 2009). Trans regulators of
ADAR proteins may help explain this variation in editing levels
(Li and Church, 2013; Sapiro et al., 2015); however, few ADAR
and editing level regulators are known. In mammals, Pin1,
WWP2, and AIMP2 regulate ADAR protein levels or localization,
leading to changes in editing levels (Behm et al., 2017; Marcucci
et al., 2011; Tan et al., 2017). Editing regulators can also be site
specific, meaning they regulate ADAR editing at only a subset of
editing sites rather than globally regulating ADAR activity.
Studies in Drosophila identified FMR1 and Maleless as site-spe-
cific regulators of editing (Bhogal et al., 2011; Reenan et al.,
2000). Further study has verified that human homologs of both
FMR1 (Tran et al., 2019) and Maleless (Hong et al., 2018), along
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with a number of other RNA-binding proteins and splicing fac-
tors, act as site-specific regulators of RNA editing. These fac-
tors, including SRSF9, DDX15, TDP-43, DROSHA, and Ro60
(Garncarz et al., 2013; Quinones-Valdez et al., 2019; Shanmu-
gamet al., 2018; Tariq et al., 2013), help to explain some variation
in editing levels; however, with thousands of editing sites in flies
and millions in humans (Ramaswami and Li, 2014), additional
regulators likely remain undiscovered. These previous studies
highlight RNA-binding proteins as strong candidates for editing
regulators (Washburn and Hundley, 2016). Because of the
conserved roles of Drosophila editing regulators as well as the
ability to measure nervous system phenotypes, flies serve as
an important model for understanding the regulation of editing
as it relates to human neurological diseases.
To identify regulators of RNA editing in the brain, we screened
48 RNA-binding proteins for regulation of editing levels using
RNA interference (RNAi) in Drosophila neurons. We identified
zinc-finger protein at 72D (Zn72D) as a regulator of RNA editing
at nearly two-thirds of assayed editing sites. Zn72D knockdown
led to a decrease in ADAR protein levels, although that decrease
did not fully explain the editing-level changes. We further deter-
mined that Zn72D and ADAR physically interact in the brain by
binding RNA. In addition to editing changes, loss of Zn72D also
led to defects at the neuromuscular junction (NMJ) and impaired
locomotion in the fly. Finally, we found that the mouse homolog
of Zn72D, Zfr, regulates editing levels in primary cortical neurons,
suggesting this mode of editing regulation is highly conserved.
RESULTS
An RNAi Screen Identifies Zn72D as a Dramatic
Regulator of RNA Editing
To better understand how ADAR editing is regulated in the brain,
we designed an in vivo screen to identify regulators of editing in
Drosophila. Because RNA-binding proteins (RBPs) have critical
roles in RNA processing and regulate a number of editing events
in flies and mammals, we chose to focus on RBPs as candidate
regulators of editing. We created a collection of UAS-shRNA fly
lines targeting annotated RBPs, as well as GFP as a control, as
done previously (Ni et al., 2011). To assay whether loss of these
RBPs influenced editing levels, we designed a simple screen in
which we crossed UAS-shRNA lines targeting an RBP or GFP
to the pan-neuronal driver C155-Gal4 (Figure 1A). We then ex-
tracted RNA and produced RNA sequencing (RNA-seq) libraries
from two biological replicates of adult knockdown brains. We
determined editing levels by calculating the percentage of G-
containing reads at adenosines known to be editing sites in con-
trol and knockdown brains to identify sites regulated by these
RBPs. To validate that approach, we first checked the reproduc-
ibility of editing levels between biological replicates of GFP RNAi
brains used in the screen as a control and found that editing
levels among replicates were highly reproducible (Figure 1B).
We then tested the design of the screen by knocking down
Adar using two independent short hairpin RNA (shRNA) lines
(BDSC28311 and VDRC7763), which reduced AdarmRNA levels
by 60% and 72%, respectively. We compared editing levels be-
tween two replicates of each Adar knockdown (shAdar) and
matched replicates of GFP knockdown (shGFP) at previously
identified editing sites. To avoid looking at single nucleotide
polymorphisms (SNPs) or false-positive editing sites, we limited
the sites queried in our screen to those that were reproducibly
edited in controls and altered by Adar knockdowns in these pilot
experiments. In total, we identified 1,236 editing sites that were
edited reproducibly in the independent sets of GFP RNAi repli-
cates and were reduced significantly by the stronger Adar
knockdown as measured by Fisher’s exact tests (Figure 1C).
We then crossed shRNA lines targeting 48different RBPs, start-
ing with RBPs that are highly expressed in the brain (Table S1). Of
the 48 knockdowns, 17 caused lethality before adulthood and
were not screened for editing changes. For the 31 knockdowns
that were viable as adults, we performed qPCR to determine the
level of knockdown of the target: 19 knockdowns showed greater
than 40% reduction of the target mRNA, and we made RNA-seq
libraries from two replicates of eachof those knockdowns and two
GFP-targeting controls. We then determined editing levels at the
1,236 sites that were affected byAdar knockdowns. Editing levels
among all biological replicates used in the screen were highly
reproducible, similar to shGFP replicates (Figure S1A). We deter-
mined whether sites differed between control and RBP knock-
downs using Fisher’s exact tests comparing the total number of
A and G reads from the biological replicates combined. Figure 1D
shows the number of editing sites with increased or decreased
editing levels in each RBP knockdown compared with the GFP
controls, as well as the knockdown efficiency for each target as
measured by RNA-seq (Table S1). Most RBP knockdowns
showed evidence of positive or negative regulation of editing at
fewer than 50 editing sites (Figures 1D and S1B). TwoRBP knock-
downs had slightly wider-ranging effects on editing levels. Knock-
down ofRbp6 decreased editing at 72 sites and increased editing
at 2 sites, and knockdown of pasilla decreased editing at 193 sites
and increased editing at 15 sites. By far the most robust regulator
of RNA editing, however—in terms of both the number of sites
altered and the strength of the effect—was Zn72D. Knockdown
ofZn72D decreased editing at 670 editing sites and increased ed-
iting at 44 sites, affecting 59% of sites measured (Figure 2A). This
dramatic regulation of editing exceeded that of all other RBPs
screened as well as others previously reported to regulate
ADAR editing (Washburn and Hundley, 2016); therefore, we
focused on characterizing Zn72D in this work.
Zn72DKnockdownAlters RNAEditing andADARProtein
Levels
Because Zn72D had the strongest effect on editing in our RNAi
screen, we wanted to first validate the site-specific nature of
that regulation (Figure 2A). Thus, we crossed an independent
UAS-shZn72D line (BDSC55635) to C155-Gal4 and sequenced
the RNA to confirm the editing-level changes. We observed a
similar editing phenotype with that independent shRNA line,
with the increased and decreased editing sites showing the
same responsiveness to Zn72D knockdown with both shRNAs
(Figures S2A and S2B; Table S1). To verify that the editing
phenotype was not a consequence of the RNAi system itself or
of off-target effects, we measured editing in Zn72D mutants.
We crossed two Zn72D mutant alleles, Zn72D1 and Zn72D1A14,
which caused premature stop codons at amino acids 38 and
559, respectively. The resulting Zn72D1/1A14 mutant flies died




as pupae, as previously reported (Brumby et al., 2004), so we
collected heads approximately 72 h after puparium formation
and sequenced the RNA to check editing levels. Zn72D1/1A14
pupal heads showed large differences in editing from wild-type
pupal heads (Figure 2B; Table S1). We compared the changes
in editing observed in the Zn72D knockdowns (shZn72D) to
those in the Zn72Dmutants. Despite the difference in the devel-
opmental stage of the flies, both the increases and decreases in
editing levels caused by Zn72D knockdownwere similar to those
in the mutants (Figure 2C), confirming that the Zn72D editing
phenotype was highly reproducible and site specific.
Of the editing sites affected by Zn72D knockdown, 93%
showed decreased editing levels, so we wanted to determine
whether Zn72D loss reduced Adar mRNA or protein levels. We
first checked Adar mRNA levels between shGFP and shZn72D
brains and wild-type and mutant heads. Zn72D loss did not lead
to a significant decrease in Adar mRNA levels (Figures 2D and
S2C). To checkADARprotein levels, weknockeddownZn72D us-
ing the pan-neuronal driverElav-Gal4 inAdarHA flies (Jepson et al.,
2011), where the endogenous ADARprotein is taggedwith a hem-
agglutinin (HA) epitope. We confirmed that the editing phenotype
in those flies reproduced that of the Zn72D knockdown driven by
the C155-Gal4 driver (Figures S2D–S2F). By western blot, we
found that ADAR-HA protein was decreased by 49% in Zn72D-
knockdown brains. We also crossed the mutants into the AdarHA
background, and we found that ADAR-HA levels were decreased
by 72% in AdarHA; Zn72D1/1A14 pupal heads (Figure 2E), verifying
an ADAR protein reduction upon loss of Zn72D.
Zn72D and Adar Knockdowns Have Divergent Editing
Phenotypes
Although a decrease in the ADAR protein may explain some ed-
iting decreases in the Zn72D knockdown and mutant flies, that
finding did not appear to fully explain the complex editing
Figure 1. An RNAi Screen Identifies Zn72D as a Regulator of RNA Editing
(A) Schematic of RNAi screen. Pan-neuronal driverC155-Gal4was crossed toUAS-shRNA flies targeting 1 of 20 different RNA-binding proteins. RNA from brains
was sequenced to compare editing levels between C155-Gal4; UAS-shGFP controls and C155-Gal4; UAS-shRBP flies.
(B) Comparison of editing levels across two biological replicates of shGFP controls. Biological replicates were highly reproducible.
(C) Comparison of editing levels between C155-Gal4; UAS-shGFP and C155-Gal4; UAS-shAdar (VDRC7763) at sites used in the screen. All sites are reduced by
Adar knockdown. Blue dots, p < 0.05, Fisher’s exact tests.
(D) The number of editing sites found to be increased or decreased (p < 0.05, Fisher’s exact tests) upon knockdown of each of 20RBPs screened. Heatmap shows
the log2-fold change of each target RBP between knockdown and control as measured by RNA-seq. shZn72D shows the greatest number of altered editing sites
besides shAdar.




phenotype observed. Unlike the Adar knockdown, the Zn72D
knockdown did not decrease editing at all sites. To more closely
examine the differences in editing between Zn72D and Adar
knockdowns, we directly compared the editing levels in
Zn72D-knockdown brains to those in Adar-knockdown brains.
The stronger Adar knockdown (VDRC7763; see Figure 1C)
decreased editing more than the Zn72D knockdown did at 634
sites and less than the Zn72D knockdown at only seven sites
(Figure 3A). Concordantly, when crossed into the AdarHA back-
ground, thisAdar knockdown showed amore dramatic decrease
in ADAR protein than Zn72D knockdown did (Figure 3B). The
weaker of our two Adar shRNAs (BDSC28311) significantly
decreased editing compared with controls at nearly all editing
sites but to a lesser extent (Figure 3C). Compared directly to
Zn72D knockdown, this Adar knockdown diverged strongly at
many sites in both directions, decreasing editing more than
Zn72D knockdown did at 279 sites and less than Zn72D knock-
down had at 145 sites. It was similar to Zn72D knockdown at 621
sites (Figure 3D). This Adar shRNA did not decrease AdarHA
mRNA or protein levels or alter editing in theAdarHA background,
so we were unable to compare ADAR protein levels between
these knockdowns. Still, the editing differences strongly sug-
gested that Zn72D knockdown altered editing in a manner that
did not neatly resemble a decrease in Adar.
The distinct nature of Zn72D editing regulation was also clear
across editing sites found in the same transcript. For example,
the highly edited transcript paralytic (para) had multiple editing
sites that showed different editing changes in response to
Zn72D and Adar knockdowns. Figure 3E shows editing levels
in para at 15 highly edited sites (>20% in controls) in shGFP,
shAdar (BDSC28311), and shZn72D brains. At six sites in para,
Zn72D and Adar knockdowns led to similar editing decreases
(Figure 3E, coordinates in black), whereas at four sites Adar
knockdown decreased editing more than Zn72D knockdown
did (Figure 3E, coordinates in blue), and at five sites, Zn72D
knockdown decreased editing more than Adar knockdown had
(Figure 3E, coordinates in orange). Those sites with different re-
sponses toZn72D knockdown could be foundwithin a few bases
of each other, as seen at three editing sites in para located within
four bases of each other (chrX:16471811 to chrX:16471814).
Another transcript, quiver (qvr), showed similar patterns,
including differences between Zn72D and Adar knockdowns
Figure 2. Zn72D Knockdown Alters RNA Editing and ADAR Protein Levels
(A) Comparison of editing levels at individual editing sites (dots) between C155-Gal4; UAS-shGFP and C155-Gal4; UAS-shZn72D, from the RNAi screen in
Figure 1. Orange dots, p < 0.05, Fisher’s exact tests.
(B) Comparison of editing levels between two replicates ofw1118 and Zn72D1/1A14 pupal heads. Orange dots, p < 0.05, Fisher’s exact tests. Many sites are altered
in both Zn72D knockdowns and mutants compared with controls.
(C) Comparison of the difference in editing between C155-Gal4; UAS-shZn72D and C155-Gal4; UAS-shGFP and Zn72D1/1A14 and w1118 from (A) and (B). The
same sites are significantly altered in both knockdowns and mutants. Orange dots, p < 0.05 in both.
(D) Log2-fold change of Zn72D and Adar mRNA levels in C155-Gal4; UAS-shZn72D compared with C155-Gal4; UAS-shGFP adult brains and Zn72D
1/1A14
compared with w1118 pupal heads. Adar mRNA levels are not decreased in Zn72D knockdown and mutants. ***p < 0.0001, ns, p > 0.05, Wald tests. n = 2, error
bars indicate SE.
(E) Western blot of ADAR-HA protein in Elav-Gal4 / shGFP and Elav-Gal4 / shZn72D adult brains and w1118 and Zn72D1/1A14 pupal heads. n = 3, a representative
result is shown. At right, quantification of HA loss in Zn72D knockdown and mutant compared with controls, normalized to glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH). ADAR-HA protein levels are decreased in both Zn72D knockdown and mutants. Data are represented as means ± SE.




and vastly different effects of Zn72D knockdown on four sites
that were all more than 70% edited in controls and located within
23 bases of each other (chr2R:11447601 to chr2R:11447623)
(Figure S3A). To better understand how Zn72D affected editing
differently across sites within the same transcript, we compared
phenotypes within all transcripts. Of 187 transcripts in which we
measured editing at multiple editing sites, 131 (70%) included at
least one site that was affected and at least one site that was not
affected by Zn72D knockdown (Figure S3B). Those transcripts in
which all sites were either affected or unaffected by Zn72D
tended to contain fewer editing sites than those that showed
mixed effects (Figure S3C). These results suggested that
Zn72D’s site-specific effect on editing was highly localized
down to individual editing sites, distinct from a global decrease
in ADAR protein.
Zn72D Interacts with ADAR and ADAR-Target mRNAs
Because decreases in ADAR protein levels did not explain the
Zn72D knockdown editing phenotype, we hypothesized that
site-specific regulation of editing by Zn72D might result from
the protein binding the same transcripts as ADAR, as has been
previously demonstrated for other known site-specific regulators
of editing (Bhogal et al., 2011;Honget al., 2018;Quinones-Valdez
et al., 2019; Rajendren et al., 2018; Shanmugam et al., 2018). We
first askedwhether Zn72D andADARproteinswere both found in
the nucleus, where most editing in Drosophila occurs (Rodriguez
Figure 3. Zn72D and Adar Knockdowns Have Divergent Editing Phenotypes
(A) Comparison of RNA editing levels betweenC155-Gal4; UAS-shZn72D (screen) andC155-Gal4; UAS-shAdar (VDRC7763; editing levels compared with shGFP
in Figure 1C). Blue sites, p < 0.05, Fisher’s exact tests,Adar knockdown decreases editingmore than Zn72D knockdown does. Gray sites, p > 0.05, shAdar equals
shZn72D editing. Orange sites, p < 0.05, Fisher’s exact tests, Zn72D knockdown decreases editing more than Adar knockdown does. The number of sites falling
into each category is shown.
(B) Western blot comparing the level of ADAR-HA protein in AdarHA;UAS-shGFP / Elav-Gal4, AdarHA ; UAS-shZn72D / Elav-Gal4, and AdarHA ; UAS-shAdar
(VDRC7763) / Elav-Gal4. n = 3, a representative result is shown. This Adar knockdown leads to a greater reduction in ADAR-HA protein than Zn72D knockdown
does, consistent with the editing level comparison in (A).
(C) Comparison of RNA editing levels between C155-Gal4; UAS-shGFP and C155-Gal4; UAS-shAdar (BDSC28311). Blue sites, p < 0.05, Fisher’s exact tests.
(D) Comparison of RNA editing levels betweenC155-Gal4; UAS-shZn72D (screen) andC155-Gal4; UAS-shAdar (BDSC28311). Blue sites, p < 0.05, Fisher’s exact
tests, Adar knockdown decreases editing more than Zn72D knockdown does. Gray sites, p > 0.05, shAdar equals shZn72D editing. Orange sites, p < 0.05,
Fisher’s exact tests, Zn72D knockdown decreases editing more than Adar knockdown does. The number of sites falling into each category is shown.
(E) Editing levels in C155-Gal4; UAS-shGFP, C155-Gal4; UAS-shAdar, and C155-Gal4; UAS-shZn72D brains in para. Sites within the transcript are differentially
affected by Zn72D loss. n = 2, data are represented as means ± SD. *p < 0.001, ns, p > 0.05, Fisher’s exact tests between shGFP and either shAdar (above blue
bar) or shZn72D (above orange bar). Orange coordinates, shZn72D decreases editing more than shAdar does. Black coordinates, no difference between shAdar
and shZn72D. Blue coordinates, shAdar decreases editing more than shZn72D does. Blue and orange, p < 0.001, Fisher’s exact tests.




et al., 2012). Using a GFP-exon-trap allele of Zn72D, Zn72DGFP
(Zn72DCA07703; BDSC50830) that expresses a GFP-tagged
version of Zn72D from the endogenous locus (Morin et al.,
2001), we used immunofluorescence microscopy to determine
the localization of both ADAR and Zn72D proteins in AdarHA;
Zn72DGFP flies. We found that ADAR and Zn72D colocalize in
the nuclei in the brain, along with a nuclear marker in the neuron
Elav (Figures 4A–4D).
Figure 4. Zn72D Interacts with ADAR in an RNA-Dependent Manner
(A–D) Immunofluorescent staining of Elav (A), ADAR-HA (B), Zn72D-GFP (C), and all three merged (D) in the adult fly brain. All proteins are expressed in neuronal
nuclei. Images are a single slice, scale bar: 50 mm.
(E) Western blots of HA and GFP after immunoprecipitation of ADAR-HA from Zn72DGFP (control) and AdarHA; Zn72DGFP heads. Half of each IP was treated with
RNase A. Blots of HA, GFP, and GAPDH from 1% of input material are shown. n = 3, a representative result is shown.
(F) Western blots of HA andGFP after immunoprecipitation of Zn72D-GFP from AdarHA; Zn72DGFP head nuclei. Half of each IP was treated with RNase A. Blots of
HA, GFP, and Lamin from 1% of input material are shown. n = 3, a representative result is shown. ADAR-HA and Zn72D-GFP interact in the presence of RNA.
(G) Scatterplot of transcript enrichment in Zn72D-GFPRIP-seq. Log2-fold change expression in RIP samples comparedwith 5% input is plotted versus the log2 of
the average transcripts per kilobase million (TPM) of each transcript (dot) in the input samples. Orange dots, transcripts have editing sites affected by Zn72D.
Black dots, p < 0.05,Wald tests. Triangles represent points falling outside of graph boundaries. n = 3; 185 of 216 transcripts measured with editing sites altered by
Zn72D knockdown are enriched in the RIP.
(H) Enrichment of qvr, cac, Shab, para, and negative controlRpL13 recovered in the Zn72D-GFP RIP, normalized to IgG control RIP and to enrichment of negative
controlRpL32, asmeasured by qPCR. n = 3, error bars represent SE; p values, paired two-tailed t tests. Transcripts enriched in the RIP asmeasured by RNA-seq
(G) are also enriched when measured by qPCR.




We next tested whether ADAR and Zn72D proteins physically
interacted. We immunoprecipitated ADAR-HA from AdarHA;
Zn72DGFP fly-head lysates and Zn72DGFP fly-head lysates as
negative controls. Zn72D-GFP co-immunoprecipitated with
ADAR-HA in the anti-HA IP in AdarHA; Zn72DGFP head lysates.
However, after treatment with RNase A, the interaction was
significantly weakened, suggesting that the two proteins interact
in an RNA-dependent manner (Figure 4E). We subsequently per-
formed the reciprocal co-immunoprecipitation (coIP) in nuclear
lysates from heads of AdarHA; Zn72DGFP flies, using AdarHA flies
as a negative control. We found that ADAR-HA co-immunopre-
cipitated with Zn72D-GFP in nuclear lysates from flies express-
ing both tagged proteins but not after RNase A treatment
(Figure 4F), which suggested that ADAR and Zn72D interact in
an RNA-dependent manner within the nucleus.
The RNA-dependent interaction between Zn72D and ADAR
suggested that the proteins interact by binding the same RNAs
or are found within the same ribonucleoprotein (RNP) complexes.
We hypothesized that Zn72D interacts with the transcripts con-
taining editing sites affectedbyZn72D knockdown.Weattempted
to perform single-end enhanced crosslinking and immunoprecip-
itation sequencing (seCLIP-seq) (Van Nostrand et al., 2017) on
Zn72D-GFP from fly heads to determine Zn72D’s RNA-binding
sites but saw little evidence of RNA binding, likely because of
the inefficiency of crosslinking proteins to double-stranded RNA
(dsRNA) in vivo using UV light (Wheeler et al., 2018). Instead, we
performed RNA immunoprecipitation and sequencing (RIP-seq)
on Zn72D by pulling down Zn72D-GFP and its interacting RNAs
from fly heads without crosslinking, extracting RNA from inputs
and immunoprecipitations (IPs) and making RNA-seq libraries.
For negative controls, we split lysates in half and incubated one-
half with immunoglobulin G (IgG) antibody rather than GFP anti-
body; these negative controls did not immunoprecipitate enough
RNA to amplify RNA-seq libraries, suggesting our pull-down was
specific to RNAs bound by Zn72D-GFP. To determine transcript
enrichment in the RIP,we counted the sequencing readsmapping
to each gene in both the IP libraries and matched input libraries
made from RNA extracted from 5% of the input lysates. We
then used those counts as inputs to DESeq2 (Love et al., 2014)
to determine genes with increased or decreased expression in
the RIP compared with the input. We found that, of the 216 tran-
scripts sequenced in the RIP with at least one editing site affected
by Zn72D, 185 (86%) were significantly enriched in the RIP over
the input (Figure 4G; Table S2). To validate the results of the
RIP-seq, we used qPCR to quantify the relative levels of qvr,
cac, para, Shab, and the negative control RpL13 in the three bio-
logical replicates of GFP IPs, IgG negative control IPs, and their
matched inputs (Figure 4H). From three technical replicates of
three biological replicates per IP, we calculated the fold enrich-
ment of each transcript of interest over the enrichment of a nega-
tive control transcript RpL32 after normalizing to the IgG-negative
control IPs. We found that qvr, cac, para, and Shab, but not
RpL13, transcripts showed between 2- and 6-fold enrichment
over RpL32 in the Zn72D-GFP IP samples after normalization to
the IgG IPs and input amounts. Taken together, these experi-
ments support the hypothesis that Zn72D interacts with the
same RNAs as ADAR does, which may help explain its role as a
site-specific regulator of editing levels.
Because many edited transcripts immunoprecipitated with
Zn72D, and Zn72D and its human homolog ZFR both have re-
ported roles in regulating pre-mRNA splicing (Haque et al.,
2018; Worringer and Panning, 2007), we determined whether
Zn72D knockdown led to splicing changes in the fly brain. To
identify alternative splicing changes in Zn72D-knockdown brains
(BDSC55635; see Figure S2A) compared with shGFP controls,
we used Mixture of Isoforms (MISO) (Katz et al., 2010), which
identifies differentially regulated isoforms across samples. As
expected, Zn72D knockdown led to a change in maleless
splicing (Worringer and Panning, 2007). We further found that
Zn72D knockdown altered splicing in 40 of the 252 transcripts
in which we observed editing changes (Table S3). Those 40 tran-
scripts contained 216 of 785 editing sites (28%) altered by
Zn72D; 88 of those 216 editing sites (41%) were located within
or between the exons bordering the altered splice junction,
whereas the others were either upstream or downstream of the
differentially spliced region. We found 400 altered splicing
events in 257 transcripts; 217 of those transcripts (84%) did
not contain editing sites that were altered by Zn72D, suggesting
Zn72D regulated both splicing and editing in some transcripts
and regulated splicing and editing independently in many
transcripts.
Loss of Zn72D Leads to Impaired Locomotion and NMJ
Defects
RNA editing is necessary for proper neuronal function in the fly
(Jepson et al., 2011; Palladino et al., 2000). Because loss of
Zn72D led to such a dramatic change in RNA editing levels, we
hypothesized that it might have a similar role to ADAR in regu-
lating neuronal function. First, we tested locomotion in Zn72D-
knockdown flies. Although Zn72D mutants died as pupae,
C155-Gal4; UAS-shZn72D flies were viable into adulthood, al-
lowing us to test their climbing ability using a negative geotaxis
assay. We measured climbing in flies with GFP RNAi and
Zn72D RNAi driven by Elav-Gal4 by determining the proportion
of flies of each genotype that climbed more than halfway up a
20-cm glass vial over time. We found that an average of 36%
of Zn72D-knockdown flies climbed above 10 cm in a glass vial
after 2 min compared with 100% of GFP-knockdown flies (Fig-
ure S4A). This climbing defect was more severe than what we
observed for Adar knockdown, suggesting that Zn72D knock-
down led to a locomotion phenotype that was distinct from
Adar knockdown. In an independent test of GFP and Zn72D
RNAi driven by C155-Gal4, 46% of Zn72D-knockdown flies
were found above the 10-cm mark after 5 min compared with
100% of GFP-knockdown flies (Figure S4B).
To more deeply explore the cellular basis for this locomotor
defect, we examined how the loss of Zn72D affected the
morphology and organization of synapses at the NMJ. ADAR is
necessary for proper synaptic architecture and function at the
NMJ (Bhogal et al., 2011; Maldonado et al., 2013), and because
Zn72D regulates ADAR editing at many sites, we hypothesized
that it may similarly be necessary for NMJ organization. In
Zn72D mutants, we examined synaptic morphology and
observed a 6-fold increase in the number of satellite boutons
(Figures 5A–5D and I), a defect typically associated with
impaired endocytic cycling and BMP signaling (Dickman et al.,




2006; O’Connor-Giles et al., 2008). In vesicle-cycling mutants,
such as synaptotagmin I (syt I), endophilin, and synaptojanin,
there is a marked increase in satellite bouton number. To deter-
mine whether any of those endocytic proteins were affected by
the loss of Zn72D, we used immunocytochemistry to examine
Syt I levels at the NMJ. At Zn72D-mutant NMJs, Syt I levels
were decreased by 31% (Figures 5A–5D and J), suggesting a po-
tential mechanism by which the loss of Zn72D results in exces-
sive satellite boutons. Intriguingly, loss of ADAR increased levels
of Syt I (Maldonado et al., 2013), suggesting that Zn72D and
ADAR can regulate the levels of synaptic proteins differently.
Consistent with that difference, Adar mutants lacked the
increased number of satellite boutons (Bhogal et al., 2011), sug-
gesting that both mutants regulate aspects of NMJ architecture
differently. However, we also observed similarities between
ADAR and Zn72D regulation of protein levels at the NMJ. Loss
of ADAR also alters the levels of postsynaptic GluRIIA receptors
Figure 5. Loss of Zn72D Regulates NMJ Ar-
chitecture and Protein Levels
(A–D) Third instar larvae stained with antibodies
against Syt I (red) and HRP (cyan) in Control (A and
B) and Zn72D1A14/Df mutant larvae (C and D). Df is
Df(3L)Exel6127, which lacks the Zn72D locus. As-
terisks indicate satellite boutons. Loss of Zn72D
markedly increases the incidence of satellite bou-
tons and reduces the apparent fluorescent intensity
of Syt I staining.
(E–H) Third instar larvae stained with antibodies
against GluRIIA (green) and HRP (magenta) in
Control (E and F) and Zn72D1A14/Dfmutant larvae (G
and H). Loss of Zn72D reduces synaptic GluRIIA
staining. Scale bar, 10 mm.
(I–K) Quantification of satellite boutons per NMJ (I),
Syt I fluorescence levels (J) and GluRIIA fluores-
cence levels (K). Multiple allelic combinations of
Zn72D mutants show increased satellite bouton
numbers and reduced Syt I and GluRIIA staining.
Both GluRIIA and Syt I fluorescence levels are
normalized to HRP staining at the same NMJs,
which is unchanged across all genotypes, sug-
gesting that these deficits are specific. For all
graphs, open circles represent each individual
value while the mean ± SEM is indicated by the
error bars. In all cases, n R 7 animals, 14 NMJs for
each genotype. *p < 0.05, **p < 0.01, ***p < 0.001,
ANOVA followed by a Dunnett’s multiple compari-
sons test.
(Maldonado et al., 2013); this is thought to
be in response to changes in presynaptic
function. Multiple allelic combinations of
Zn72D mutants show a 32% reduction in
synaptic GluRIIA staining (Figures 5E–5H
and K); this is consistent with the 37%
reduction observed in ADAR mutants
(Maldonado et al., 2013). Together with
the changes in morphology and synaptic
Syt I intensity, these results suggest that
NMJ phenotypes arising from the loss of
Zn72D cannot be completely explained
by a loss of ADAR editing. Rather, there are likely to be ADAR-
dependent and ADAR-independent roles of Zn72D in regulating
NMJ synapse organization.
Zn72DRegulation of Editing Is Conserved inMammalian
Neurons
We next sought to determine whether the regulation of ADAR and
RNA editing levels by Zn72D was conserved in mammals, as has
been demonstrated for other regulators of RNA editing identified
in flies (Bhogal et al., 2011; Hong et al., 2018). We designed
shRNAs against mouse Zfr, the mammalian homolog of Zn72D,
as well as Adar2, which encodes the homolog of Drosophila
ADAR, and Adar1, which encodes the other catalytically active
mammalian ADAR protein (Figure 6A). We depleted Adar1,
Adar2, and Zfr from mouse primary cortical neurons, and per-
formed RNA-seq. We compared editing levels between two com-
bined biological replicates of primary neurons transfected with




control shRNAs to those transfected with shRNAs targeting
Adar1, Adar2 and Zfr (Figures 6B–6D). In each knockdown, we
found more than 100 sites with decreased editing levels, demon-
strating that Zfr knockdown alters editing levels in thismammalian
neuronal context (Table S4). Among the sites affected by Zfr was
the Gria2 Q/R site that is known to have a critical role in neuronal
function (Horsch et al., 2011). We compared the sites decreased
upon knockdown ofAdar1, Adar2, and Zfr and found that all three
knockdowns altered a distinct subset of editing sites. Of note, the
set of sites decreased by Zfr knockdownmore closely overlapped
with those decreased byAdar2 knockdown than those decreased
by Adar1 knockdown (Figure 6E). This finding is consistent with
our findings in Drosophila, because the single ADAR enzyme is
a closer homolog of mammalian ADAR2 in sequence and in func-
tion (Keegan et al., 2011).
Because Zfr affected mostly ADAR2-regulated sites, we used
the RNA-seq data to measure Adar1, Adar2, and Zfr mRNA
expression levels in all three knockdowns. We found that Zfr
knockdown led to a decrease in Adar2 mRNA expression (Fig-
ure 6F), suggesting that Zfr regulated Adar2 levels in mouse
primary neurons. Further supporting an ADAR2-centric role for
editing level regulation by Zfr, we found that knocking down
ZFR in human HEK293T cells (Haque et al., 2018) led to no
change in editing (Figures S5A–S5C; Table S4). Unlike mouse
primary neurons, Adar2 is scantily expressed in HEK293T cells
(Figure S5D), and therefore, ADAR1 is likely responsible for
most editing events in these cells. Taken together, these data
suggest that the broad mechanisms of Zn72D regulation of edit-
ing—regulating both ADAR levels and editing at specific sites—
are conserved in the mouse brain between Zfr and ADAR2.
DISCUSSION
RNA editing is dynamically regulated during development and
across tissue and cell types (Graveley et al., 2011; Sapiro
et al., 2019; Tan et al., 2017; Wahlstedt et al., 2009), but few fac-
tors responsible for that regulation are known. Because RBPs
such as ADAR form extensive cross-regulatory networks (Dassi,
2017), they are top-candidate editing regulators, and many
known regulators of editing are proteins that interact with ADARs
by binding the same RNAs (Quinones-Valdez et al., 2019; Wash-
burn and Hundley, 2016). Our previous work suggested a role for
trans regulators of editing in the fly brain (Sapiro et al., 2015,
2019), so we perturbed RBP levels in that context. Most of the
Figure 6. Zfr Affects Editing Levels and Adar2 mRNA Levels in Mouse Primary Neurons
(A) Schematic of protein domains of Zn72D and its mouse homolog, Zfr (top). Schematic of protein domains of Drosophila ADAR and its mouse homolog ADAR2
along with the other catalytically active mouse ADAR, ADAR1 (bottom).
(B) Comparison of editing levels between mouse primary neurons transfected with a control shRNA versus shAdar1. Blue dots, p < 0.05, Fisher’s exact tests. n = 2.
(C) Comparison of editing levels between mouse primary neurons transfected with a control shRNA versus shAdar2. Blue dots, p < 0.05, Fisher’s exact tests. n = 2.
(D) Comparison of editing levels between mouse primary neurons transfected with control shRNA versus shZfr. Orange dots, p < 0.05, Fisher’s exact tests. n = 2.
The number of changed sites is indicated. Many editing sites show decreased editing upon Adar1, Adar2, and Zfr knockdown.
(E) Venn diagram showing the overlap of affected sites between shAdar1, shAdar2, and shZfr. shZfr sites share a larger overlap with ADAR2-affected sites,
although the three sets are distinct.
(F) Log2-fold changes of mRNA levels of Adar1, Adar2, and Zfr in shAdar1, shAdar2, and shZfr neurons compared with shControl neurons. n = 2, error bars
represent SE. ***p < 0.001, ns, p > 0.05,Wald tests.Adar1 knockdown does not affectAdar2 or Zfr levels, whereasAdar2 knockdown decreases Zfr levels, and Zfr
knockdown decreases Adar2 levels.




RBPs we screened had only a small influence on editing,
suggesting that editing levels are fairly stable, even as the RBP
landscape changes. This result is consistent with our previous
finding that many editing sites have stable editing levels across
different neuronal populations in the fly brain (Sapiro et al.,
2019) as well as a study of the role of RBPs in regulating editing
levels in human cells (Quinones-Valdez et al., 2019). However,
our screen results may include false-negatives because of
incomplete knockdown. Future experiments testing additional
double-stranded RBPs for roles in RNA editing may help identify
more critical trans regulators because ADARs interact with dou-
ble-stranded RNA species (Bass, 2002).
We identified Zn72D as a broadly influential regulator of RNA
editing. This zinc finger RBP was first identified as a suppressor
of a mutation in the cell-cycle regulator cyclin E (Brumby et al.,
2004). Zn72D has three C2H2 zinc finger domains and a DZF
domain that facilitates protein dimerization and contributes to
RNA binding (Castello et al., 2016; Wolkowicz and Cook, 2012).
The mouse homolog of Zn72D, Zfr, is predicted to bind A-form
dsRNA helices because of similarities between its zinc finger do-
mains and those of other dsRNA-binding proteins: long linkers be-
tween zinc fingers, an interhistidine distance of five amino acids,
and a reversal of characteristic aromatic and hydrophobic resi-
dues (Meagher et al., 1999). Zfr alters splicing in human macro-
phages, regulating innate immunity (Haque et al., 2018), suggest-
ing it has a broad role in RNA processing. Zn72D also regulates
the male-specific lethal (MSL) dosage compensation complex in
flies by altering the splicing of maleless, which encodes a critical
member of the complex (Worringer and Panning, 2007). Interest-
ingly, a gain-of-function mutation inmaleless regulates RNA edit-
ing levels in para (Reenan et al., 2000), although loss-of-function
mutations did not have the same effect. Because the human ho-
molog of Maleless, DHX9, is also known to regulate editing
(Hong et al., 2018), some of the editing phenotype upon loss of
Zn72D may be caused indirectly through regulation of maleless.
Zn72D knockdown regulated editing at a large subset of sites,
whereas many were unaffected. We hypothesize that Zn72D fa-
cilitates ADAR editing at some sites by binding the same dsRNAs
as ADAR. Zn72D regulation of editing differs within transcripts
and even among sites found within a few bases of each other.
Although Zn72D loss leads to an overall decrease in the ADAR
protein, the effects of this loss are distributed asymmetrically
across edited adenosines, in a manner that is distinct from the
effect of knocking down Adar itself. Although some of the
observed editing decreases may be a consequence of lower
ADAR levels, we hypothesize that for at least a subset of RNA
species, the presence of Zn72D nearby alters the efficiency at
which particular adenosines are edited. For sites with increased
editing upon Zn72D knockdown, Zn72D binding may inhibit
ADAR binding when present.
Zn72D may affect editing in a number of ways. For example,
Zn72Dmay alter the structure of ADAR-bound dsRNAs bymodu-
lating splicing kinetics; however, althoughwe found 40 transcripts
with both splicing and editing changes, there were 212 transcripts
with editing changes in which we did not find evidence of splicing
changes. Although splicing efficiency can alter editing levels (Licht
et al., 2016), editing can also affect splicing (Hsiao et al., 2018),
complicating this question. Our observation that Zn72D affects
some, but not all, adenosines in clusters of linked editing sites
suggests that Zn72D could change which adenosines are edited
in certain dsRNA structures. It could also modify ADAR’s ability
to move along a substrate to edit multiple adenosines within a
few bases of each other. Future studies are needed to clarify the
precise mechanisms by which Zn72D affects ADAR function.
In addition to molecular phenotypes, we found that loss of
Zn72D leads to cellular and organismal changes; however, these
phenotypes differ somewhat from those that we or others have
found in Adar mutants and knockdown flies. For instance,
ADAR and Zn72D reduction lead to opposite effects on Syt I
levels at the NMJ, which may stem from the fact that Zn72D in-
hibits ADAR editing at only some editing sites. It is also likely that
Zn72D has ADAR-independent functions. Overall, these results
demonstrate that Zn72D has a distinct and critical role in neurons
and fly physiology.
We found that the neuronal role for Zn72D in RNA editing is
conserved inmammals. Knockdown of Zfr affectedmainly editing
sites that were regulated by ADAR2, although at a subset distinct
from those affected by Adar2 knockdown. Knockdown of Zfr also
led to a decrease inAdar2mRNA, suggesting that someportion of
the editing phenotype may be due to decreased ADAR2 levels in
mouse neurons. In a biochemical screen for proteins that interact
with human ADARs, we identified human ZFR as a top ADAR1-
and ADAR2-interacting protein and demonstrated an RNA-
dependent interaction between ZFR and ADAR1 and ADAR2
(Freund et al., 2020 [this issue of Cell Reports]). Together, these
results suggest that ZFR regulates editing inmammals by interact-
ing with ADARs on RNA. The regulation of RNA editing by ZFR
may have implications relevant to human disease. ADAR1 muta-
tions can lead to Aicardi-Goutières syndrome (AGS) (Rice et al.,
2012) and spastic paraplegia (Crow et al., 2014). These auto-im-
mune diseases can have neurological symptoms and are caused
by an increase in interferon expression after loss of ADAR1 editing
of endogenous dsRNAs. ZFR has also been implicated, through
one missense mutation, in spastic paraplegia (Novarino et al.,
2014). Although our data suggest ZFR’s effect on editing is mainly
exerted through ADAR2, rather thanADAR1, future studies should
explore the consequences of this ZFRmutation on editing inmore
human contexts. Furthermore, because targeting ADAR1 has
been shown to be an effective strategy to enhance cancer treat-
ment (Ishizuka et al., 2019; Liu et al., 2019), ZFR—either through
its regulation of editing or independent mechanisms of innate im-
mune activation (Haque et al., 2018)—may prove to be a candi-
date drug target. As a broadly influential trans regulator of
ADAR, a detailed understanding of how Zn72D and ZFR regulate
editing will provide needed insight into the RNA editing process.
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse anti-HA BioLegend (Covance) Cat#901514; RRID: AB_2565336
Rabbit anti-GFP Abcam Cat#ab290; RRID: AB_303395
Rat anti-Elav Developmental Studies Hybridoma Bank DSHB#7E8A10; RRID: AB_528218
Mouse anti-lamin (Dm0) Developmental Studies Hybridoma Bank DSHB#ADL67.10 s; RRID: AB_528336
Mouse anti-GAPDH Invitrogen Cat#MA5-15738; RRID: AB_10977387
Rabbit anti-Syt I Loewen et al., 2001; Noreen Reist Lab N/A
Mouse anti-GluRIIA Parnas et al., 2001 RRID:AB_2568752
Critical Commercial Assays
Agencourt RNAdvanced Tissue Kit Beckman Coulter Cat#A32649
KAPA SYBR Fast KAPA Biosystems Cat#KK4601
KAPA Stranded RNA-seq Kit KAPA Biosystems Cat#KK8400
KAPA HyperPrep RNA-seq Kit KAPA Biosystems Cat#KK8540
Hybridase Thermostable RNase H Lucigen (Epicenter) Cat#H39500
Deposited Data
All data generated herein as a SuperSeries This paper GEO: GSE126631
Drosophila RNAi RNA-seq Screen This Paper GEO: GSE126628
Zn72D RIP-seq This Paper GEO: GSE126630
Mouse primary neuron RNA-seq This Paper GEO: GSE126629
ZFR knockdown HEK293T RNA-seq Haque et al., 2018 GEO: GSE99231
Experimental Models: Cell Lines




D. melanogaster: AdarHA Jepson et al., 2011 FlyBaseID: FBal0298344
D. melanogaster: Zn72DGFP (y[1] w[*]; P{w
[+mC] = PTT-GA}Zn72D[CA07703])
Bloomington Drosophila Stock Center BDSC50830
D. melanogaster: RNAi lines, see Table S1 This Paper; Bloomington Drosophila Stock
Center; Vienna Drosophila Resource Center
N/A
D. melanogaster: Adar5G1 Palladino et al., 2000 FlyBaseID: FBal0118605
D. melanogaster: Zn72D[1]/TM2 Bloomington Drosophila Stock Center BDSC5061
D. melanogaster: w[*]; Zn72D[1A14]/TM6B,
Tb[+]
Bloomington Drosophila Stock Center BDSC32668
D. melanogaster: Zn72DDf (w[1118]; Df(3L)
Exel6127, P{w[+mC] = XP-U}Exel6127/
TM6B, Tb[1])
Bloomington Drosophila Stock Center BDSC7606
Oligonucleotides
qPCR primers, see STAR METHODS Hu et al., 2013 https://www.flyrnai.org/FlyPrimerBank
rRNA oligos, see Table S5 This Paper N/A
Recombinant DNA
pGreenPuro (CMV) shRNA Expression
Lentivector
System Biosciences Cat#SI505A-1
Mouse shRNAs, see STAR METHODS This Paper N/A
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Jin Billy Li
(jin.billy.li@stanford.edu).
Materials Availability
All unique reagents generated in this study are available without restriction from the lead contact.
Data and Code Availability
The accession number for the high-throughput sequencing data reported in this work, including the RNA binding protein RNAi
screen, Zn72D-GFP RIP-seq, and the mouse primary neuron RNA-seq, is GEO: GSE126631. This SuperSeries includes the
Drosophila RNAi screen RNA-seq data (GEO: GSE126628), the Zn72D RIP-seq data (GEO: GSE126630), and the mouse primary
neuron knockdown data (GEO: GSE126629). R and python scripts used for data analysis are available upon request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Fly stocks and husbandry
RNA binding protein shRNA lines for the screen were created as in Ni et al. (2011); see Table S1 for shRNA sequences and vectors
used. C155-GAL4 (BDSC458) flies were obtained from Bloomington Drosophila Stock Center (BDSC), along with one UAS-shAdar
line (BDSC28311) and the independent UAS-shZn72D line (BDSC55635) which were created by the Transgenic Drosophila RNAi
project (TRiP) (Perkins et al., 2015). The stronger shAdar line was obtained from the Vienna Drosophila Resource Center (v7763) (Di-
etzl et al., 2007). For the RNAi screen, C155-Gal4 virgin females were crossed to males containing UAS-driven shRNAs against in-
dividual RNA binding proteins. If viable, F1 females were collected at 0-2 days old and aged for three days. Approximately 15 brains
were dissected from females for each replicate, with two replicates per shRNA line. Zn72DGFP (BDSC50830), Zn72D1 (BDSC5061),
Zn72D1A14 (BDSC32668) (Brumby et al., 2004), and Df(3L)Exel6127 (BDSC7606) (Parks et al., 2004), which deletes chromosomal re-
gion 72D1-72D9 including Zn72D and surrounding genes, were obtained from BDSC. AdarHA (Jepson et al., 2011) flies were a
generous gift from the R. Reenan lab and Adar5G1 mutants (Palladino et al., 2000) a generous gift from L. Keegan. Flies were raised
at 25C on molasses-based food on a 12 hr light/dark cycle.
Mouse primary neuron culture
Primary mouse cortical neurons of E16.5 Mus musculus (strain: C57BL/6J) from whole mixed-sexed litters were dissociated and
mixed into single cell suspensions using a papain dissociation system (Worthington Biochemical Corporation). Neurons were seeded
onto poly-L-lysine coated plates (0.1% w/v) and grown in Neurobasal media (GIBCO) supplemented with B-27 serum-free supple-
ment (GIBCO), GlutaMAX, and Penicillin-Streptomycin (GIBCO) in a humidified incubator at 37C, with 5%CO2. Half media changes
were performed every 4-5 days, or as required. For gene silencing experiments, neurons were infected the day after seeding with a
6-well pellet worth of concentrated frozen virus. The media was changed 12-16 hours later and every 4 days following (neurobasal +
B-27 + glutamine). Neurons were harvested on day 7 for RNA extractions. All mouse experiments were approved by the Stanford
Administrative Panel on Animal Care (APLAC).
Continued
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Software and Algorithms
STAR v2.54b Dobin et al., 2013 RRID:SCR_015899; https://github.com/
alexdobin/STAR
Samtools v1.9 Li et al., 2009 RRID:SCR_002105; http://samtools.
sourceforge.net/
RSEM v1.2.30 Li and Dewey 2011 RRID:SCR_013027; http://deweylab.
biostat.wisc.edu/rsem/
DESeq2 v1.22.0 Love et al., 2014 RRID:SCR_015687; https://bioconductor.
org/packages/release/bioc/html/DESeq2.
html
MISO v0.5.4 Katz et al., 2010 RRID:SCR_003124; https://miso.
readthedocs.io/en/fastmiso/





RNA extraction and cDNA synthesis
RNA was extracted from dissected brains or heads using Agencourt RNAdvanced Tissue Kit (Beckman Coulter: A32645) following
the standard protocol using one fourth of all volumes. To bind RNA to beads, final Bind Buffer was prepared by adding 10 mL of Bind
Buffer beads to 90 mL of isopropanol. Following RNA extraction, 1 mL of TURBO DNase (Invitrogen: AM1907) was used to remove
DNA by incubating for 20-30 minutes at 37C. cDNA was synthesized from half of each RNA sample using SuperScript III (Invitrogen:
18080093) following the standard protocol using random hexamers as primers. The other half of the RNA was used as input for
RNA-seq libraries.
qPCR determination of RNAi efficiency
qPCR was performed using KAPA SYBR Fast (Kapa Biosystems: KK4600) to determine whether knockdown of the target exceeded
40% before proceeding to RNA-seq. qPCR primers were designed by FlyPrimerBank (Hu et al., 2013), and primer efficiency was
tested to ensure 90%–105% efficiency. qPCR was performed on a Bio-Rad CFX96 Real-Time System. Averaging three technical
replicates, fold changes were calculated using the DDCt method for the change between the gene of interest and reference gene
GAPDH. Knockdown levels reported in Figure 1 were calculated using DESeq2 (Love et al., 2014) after RNA-sequencing.
RNA-seq library preparation
rRNA was depleted from total RNA following RNase H-based protocols adopted from Adiconis et al. (2013) and Morlan et al. (2012).
We mixed approximately 150 ng of RNA with 150 ng of pooled DNA oligos designed antisense to Drosophila rRNA in 50 base pair
sections (Table S5) in an 8 mL reaction with 2 mL of 5X Hybridization buffer (500 mM Tris-HCl pH 7.4, 1 M NaCl). We annealed
rRNA antisense oligos to total RNA samples for 2 minutes at 95C, slowly reduced the temperature to 45C and then added 2U of
Hybridase Thermostable RNase H (Epicenter, Lucigen: H39500) and 1 mL of 10X Digestion buffer (500 mM Tris-HCl, 1 M NaCl,
200mMMgCl2) and incubated for 30minutes at 45
C. rRNA-depleted RNAwas then purified using 2.2X reaction volume of Agencourt
RNAClean XP beads (Beckman Coulter: A63987), treated with TURBODNase (Invitrogen: AM1907), and then purified with RNAClean
XP beads again. rRNA-depleted RNA was used as input to the KAPA Stranded RNA-seq Kit (Kapa Biosystems: KK8400) to make
RNA-sequencing libraries for fly knockdowns. For mouse primary neuron RNA-seq libraries, the KAPA HyperPrep RNA-seq Kit
(Kapa Biosystems: KK8540) was used to create libraries after rRNA depletion using oligos antisense to human rRNA sequences
(Adiconis et al., 2013). All libraries were sequenced with 76 base pair paired-end reads using an Illumina NextSeq.
Brain immunofluorescence microscopy
Fly brains were dissected from 3-to-5-day-old adult females and stained exactly as in Wu and Luo (2006). The following primary an-
tibodies were used: mouse anti-HA antibody (HA.11, Covance, BioLegend: 901514) and rabbit anti-GFP antibody (Abcam: ab290)
were used at 1:500, and rat anti-Elav antibody (Developmental Studies Hybridoma Bank, Iowa City, IA, deposited by G. M. Ruben:
7E8A10) was used at 1:25. Cross absorbed secondary antibodies used were: goat anti-mouse IgG Alexa Fluor Plus 555 (Invitrogen:
A32727), goat anti-rabbit IgG Alexa Fluor 488 (Invitrogen: A11034), and goat anti-rat IgG Alexa Fluor 647 (Invitrogen: A21247). Brains
were imaged on an Inverted Zeiss LSM 780 Multiphoton Laser Scanning Confocal Microscope with a 20X objective.
NMJ immunofluorescence microscopy
Zn72Dmutant alleles were maintained over GFP-tagged balancer chromosomes or the larval-selectable Tb marker to enable selec-
tion as third instar larvae. Third instar larvae were dissected and stained as previously described (Mosca et al., 2012) in 0 mM Ca2+
modifiedDrosophila saline (Mosca et al., 2005). Larvaewere fixed in 4%paraformaldehyde (ElectronMicroscopy Sciences) for 20mi-
nutes (for all antibodies except GluRIIA) or in Bouin’s Fixative (ElectronMicroscopy Sciences) for 5 minutes (for GluRIIA staining). The
following primary antibodies were used: rabbit anti-Syt I at 1:4000 (Loewen et al., 2001), mouse anti-GluRIIA at 1:100 (Parnas et al.,
2001), Cy5-conjugated goat anti-HRP at 1:100 (Jackson ImmunoResearch). The following secondary antibodies were used: Alexa
488 conjugated goat anti-mouse (Jackson ImmunoResearch) and Alexa568-conjugated goat anti-rabbit (Invitrogen), both at
1:250. Larvae were imaged on a Zeiss LSM 880 confocal microscope with a 40X, NA 1.3 or a 63X, NA 1.4 lens. NMJs on muscle
4 in segment A3 on both the right and left sides were imaged and quantified. All images were scored with the experimenter blind
to genotype and processed using ImageJ (NIH) and Adobe Photoshop. Immunofluorescence was quantified using ImageJ (NIH)
and each channel (Syt I or GluRIIA) normalized to the HRP fluorescence of the corresponding image. Data was analyzed and statis-
tical analysis completed using GraphPad Prism 8.4.0.
Co-immunoprecipitation
Immunoprecipitation of ADAR-HA was performed as described in Bhogal et al. (2011) with slight modifications as follows. Flies were
flash frozen in liquid N2, their heads were removed by vortexing and then collected using a liquid N2 cooled sieve. Approximately
500 mL of fly heads were homogenized in lysis buffer (150 mM NaCl, 0.1% NP40, 20 mM HEPES (pH 7.4), 2 mM MgCl2, 1 mM
DTT, cOmplete protease inhibitor (Sigma-Aldrich: 4693159001)) for input protein. Homogenates were centrifuged at 600 xg, super-
natants were collected, and then additional lysis buffer was added, pellets were homogenized and centrifuged again, and superna-
tants combined. Half of each lysate was treated with 100 mg RNase A (Thermo Scientific: EN0531) per mg of lysate for 30 minutes on
ice. Equal amounts of lysate (approximately 1 mg) were rotated at 4C overnight with 20 mL of mouse anti-HA agarose (Sigma-
Aldrich: A2095) and washed 5X for 10 minutes each with 1 mL of lysis buffer. Protein was eluted in 2X Laemmli Sample Buffer
(Bio-Rad: 161-0747) at 95C for 10 minutes. Samples were run on 4%–15% SDS-PAGE gels (Bio-Rad: 456-1086) and transferred
to nitrocellulose membranes (Bio-Rad) for western blots. For immunoprecipitation of Zn72D-GFP, nuclei were collected from fly




heads and immunoprecipitation was performed following the protocols described in Lo Piccolo et al. (2015), with slight modifications
as follows. 20 mL of Protein G Dynabeads (Invitrogen: 10003D) were incubated with 5 mg of rabbit anti-GFP antibody (Abcam: ab290).
Following overnight incubation at 4C, IPs were washed 5 times with 1 mL of IP Wash Buffer, and Protein was eluted in 2X Laemmli
Sample Buffer (Bio-Rad) at 95C for 10 minutes. Samples were run on 4%–15% SDS-PAGE gels (Bio-Rad) and transferred to nitro-
cellulose membranes (Bio-Rad) for western blots.
Western Blotting
Antibodies used in western blots were: mouse anti-HA antibody (Covance: HA.11) at1:500, rabbit anti-GFP (Abcam: ab290) at
1:10000, mouse anti-GAPDH (Invitrogen: GA1R) at 1:2000, and mouse anti-Lamin (Developmental Studies Hybridoma Bank, depos-
ited by P. A. Fisher: ADL67.10 s) at 1:50 in 5% milk. Horseradish Peroxidase (HRP)-conjugated secondary antibodies (Jackson
ImmunoResearch) were used 1:5000. Western blots were imaged after exposing to Pierce ECL Plus Western Blotting Substrate
(Thermo Scientific: 32132) using a BioRad ChemiDoc imaging system running Image Lab Touch Software (v1.1.04). Quantification
of western blots was performed using BioRad Image Lab 5.2. Bandsweremanually traced, and adjusted volumes of HAwere normal-
ized to GAPDH controls before comparisons between genotypes.
RNA-immunoprecipitation and sequencing
RNA immunoprecipitation was performed after homogenizing three biological replicates of500 mL of fly heads in IP Buffer (150mM
NaCl, 20mMHEPES pH 7.5, 2mMMgCl2, 0.1%NP40, cOmplete protease inhibitor, RNaseOUT RNase inhibitor 1U/ mL (Invitrogen)).
Lysates were split in half, and 5% of input was removed for input control libraries. IP lysates were incubated overnight at 4C with
Dynabeads Protein G (Invitrogen: 10003D), plus 5 mg of anti-GFP antibody (Abcam: ab290) or IgG (Sigma-Aldrich: I8765). IPs
were washed 8 times in IP buffer. Beads and saved inputs were added to 1 mL of TRIzol (Thermo Fisher: 15596026). 200 mL of chlo-
roform was added, and samples were centrifuged at 14000 xg at 4C for 15 minutes. Aqueous phases were collected, mixed with 1
volume of 70% ethanol and then transferred to a RNeasy MinElute column (QIAGEN, Hilden, Germany: 74204) for purification
following the standard protocol. RIP-seq libraries were made using KAPA HyperPrep RNA-seq Kits (Kapa Biosystems: KK8540) after
rRNA depletion as described above for RNA-seq library preparation. Libraries were sequencedwith 76 base pair paired-end reads on
an Illumina NextSeq. RNA-seq reads were mapped using STAR v2.54b (–outFilterMultimapNmax 10–outFilterMultimapScoreRange
1–outFilterScoreMin 10–alignEndsType EndToEnd) (Dobin et al., 2013) to the dm6 genome (Aug 2014, BDGP Release 6 + ISO1 MT/
dm6) (Hoskins et al., 2015). Reads hitting annotated genes in the transcriptome were counted using RSEM v1.2.30 (Li and Dewey,
2011). RSEM TPMs were used for plotting and expected counts were rounded to the nearest integer and then used as input to DE-
Seq2 v1.22.0 (Love et al., 2014). Log2 fold changes were calculated using the DESeq() function followed by lfcShrink(type =
‘‘apeglm’’) (Zhu et al., 2019). For qPCR, cDNAwas made with iScript Advanced (Bio-Rad: 1708842), and qPCRwas performed using
KAPA SYBR Fast (Kapa Biosystems: KK4600) with 1 mL of input cDNA in three technical replicates for each biological replicate. All
primers were designed by FlyPrimerBank (Hu et al., 2013), and their efficiency was determined by amplification of serial dilutions.
Primer sequences and efficiencies were: RpL32 Forward 50-GCCCAAGGGTATCGACAACA, Reverse 50-GCGCTTGTTCGATCCG
TAAC, 97% efficiency; RpL13 Forward 50-GTGGTCGAGTTCCGTGAGG, Reverse 50-CCTTCTTGGGGTCTCCCTT, 98% efficiency;
qvr Forward 50-CCTTTCAACTATACAGCCCTGC, Reverse 50-TGTAACTGTGACGTACACATGC, 98% efficiency; cac Forward
50-GCGATGGCACCTTTACTGC, Reverse 50-GTGCGCCCGAATAAAACTCG, 102% efficiency; Shab Forward 50-CATCAGTCACGG
GATCAGGAT, Reverse 50-AAAGGGGCGTAGCGAACTTC, 105% efficiency; para Forward 50-ACGAGGATGAAGGTCCACAAC,
Reverse 50- ACGACGTATCGGATTGAATGG, 100% efficiency. GFP and IgG RIP Cts were normalized to inputs: DCt [RIP] = (Ct
[RIP] – Ct [Input]). Fold changes for each replicate of each transcript of interest were calculated for the Zn72D-GFP RIPs normalized
to the IgGRIPs after input subtraction, and then further normalized to the fold change of negative control transcriptRpL32, so that the
fold changes represented in Figure 4 are: 2-(DCt[GFP-input] – DCt[IgG-input]) for transcript of interest / 2-(DCt[GFP-input] – DCt[IgG-input]) forRpL32.
Since samples were normalized to IgG RIP within the same replicate, IgG fold changes are 1 with no error. Paired two-tailed t tests
were performed using GraphPad Prism 8.
Climbing assay
The negative geotaxis assay was performed with groups of 10 flies at a time counting the number of flies above the 10 cmmark on a
glass vial every 30 s or 1 minute. Flies were given 24 hours to recover from CO2 exposure before tests.
Lentivirus production
shRNAs targeted against mouse Adar1 (50-CTCACTGAGGACAGGCTGGCGAGATGGTG), Adar2 (50-AGCAATGGTCACTCCAAG
TACCGCCTGAA), and Zfr (50-GAGTATACTGTGTTGCACCTTGGC), and non-targeting controls (control #1, matched with Adar1
and Adar2 knockdowns: 50-ATCGCACTTAGTAATGATTGAA; control #2, matched with Zfr knockdown: 50-AACCGATGT
ACTTCCCGTTAAT) were cloned into the pGreenPuro backbone fromSystemBiosciences. This construct was used to produce lenti-
virus in a 6-well according to standard protocols in HEK293T cells using the third-generation system and concentrated 1:100 with
lenti-X (Clontec). The virus pellet was stored at 80C.
Gene Knockdown in Mouse Primary Neurons
Primary mouse cortical neurons were dissociated into single cell suspensions from E16.5 mouse (strain: C57BL/6J) cortices using a
papain dissociation system (Worthington Biochemical Corporation, Lakewood, NJ). Neurons were seeded onto poly-L-lysine coated
plates (0.1% w/v) and grown in Neurobasal media (GIBCO) supplemented with B-27 serum-free supplement (GIBCO), GlutaMAX,
and Penicillin-Streptomycin (GIBCO) in a humidified incubator at 37C, with 5% CO2. Half media changes were performed every




4-5 days, or as required. For gene silencing experiments, neurons were infected the day after seeding with a 6-well pellet worth of
concentrated frozen virus (see above). The media was changed 12-16 hours later and every 4 days following (neurobasal + B-27 +
glutamine). Neurons were harvested on day 7 and RNA was extracted using the PARIS kit from Ambion followed by TURBO DNase.
Adar1, Adar2, and control shRNA#1 knockdowns were matched from the same mouse, while Zfr and control shRNA#2 knockdowns
were matched from the same mouse. 250 ng of RNA was used to make RNA-seq libraries using the KAPA HyperPrep Kit from two
biological replicates of each genotype. For Adar2 knockdowns, we sequenced three technical replicates of the first biological repli-
cate and combined all A and G counts to increase coverage. Editing levels were determined after requiring 20X coverage total. Adar
and Zfr mRNA expression changes between groups were determined using DESeq2.
QUANTIFICATION AND STATISTICAL ANALYSIS
RNA Editing Level Quantification
RNA-seq reads were mapped using STAR v2.54b (–outFilterMultimapNmax 10–outFilterMultimapScoreRange 1–outFilterScoreMin
10–alignEndsType EndToEnd) (Dobin et al., 2013) to the dm6 genome (Aug 2014, BDGP Release 6 + ISO1 MT/dm6) (Hoskins et al.,
2015). Mapped reads were filtered for primary hits only. Editing levels were determined using the Samtools v1.9 (Li et al., 2009) mpi-
leup command to count A and G reads at known editing sites from Duan et al. (2017), Graveley et al. (2011), Mazloomian and Meyer
(2015), Ramaswami et al. (2015, 2013), Rodriguez et al. (2012), Sapiro et al. (2015), St Laurent et al. (2013), Yu et al. (2016), and Zhang
et al. (2017).We required 20X coverage in each replicate, except for in Zn72Dmutant versuswild-type pupal head andmouse primary
neuron comparisons, where we required 20X coverage total between the two replicates. A and G counts from two replicates of each
shRNA or mutant combined were compared to A and G counts from two control replicates combined using Fisher’s exact test with a
Benjamini-Hochberg multiple hypothesis testing correction in R v3.5.1 (Benjamini and Hochberg, 1995).
Gene Expression Quantification
Gene expression levels were determined by counting reads hitting annotated genes in the transcriptome using RSEM v1.2.30 (Li and
Dewey, 2011). RSEM outputted expected counts were rounded to the nearest integer and then used as input to DESeq2 v1.22.0
(Love et al., 2014). The DESeq() and results() functions were used to calculate gene expression differences between pairs of cell
types, using Wald tests with Benjamini-Hochberg multiple hypothesis testing corrections.
Splicing Event Quantification
To analyze splicing changes in Zn72D knockdown flies, we trimmed all reads to 75 bp and then mapped reads using STAR v2.54b
(–twoPassMode Basic), filtering for uniquely mapped reads. We ran MISO (Katz et al., 2010) after merging reads from two biological
replicates of shGFP and shZn72D (BDSC55635). We used the modENCODE Drosophila splice junctions available through MISO
(https://miso.readthedocs.io/en/fastmiso/annotation.html), lifted over from dm3 to dm6 using the UCSC Genome Browser LiftOver
function (http://genome.ucsc.edu). After comparing events, we filtered for significant changes using–num-inc 1–num-exc 1–num-
sum-inc-exc 10–delta-psi 0.12–bayes-factor 20.
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